We are live on ! Find out more
EOJOAM

E. Ohman J:or Asset Management Portfolio holdings

AUM $4.3B
1-Year Est. Return 29.55%
This Fund
S&P 500
This Quarter Est. Return
+6.12%
1 Year Est. Return
+29.55%
3 Year Est. Return
+110.24%
5 Year Est. Return
+144.75%
10 Year Est. Return
+695.34%
AUM
$1.13B
AUM Growth
+$133M
Cap. Flow
+$76.8M
Cap. Flow %
6.83%
Top 10 Hldgs %
29.98%
Holding
565
New
6
Increased
343
Reduced
14
Closed
6

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$11.6M
2
IBN icon
ICICI Bank
IBN
+$6.87M
3
VZ icon
Verizon
VZ
+$6.14M
4
PANW icon
Palo Alto Networks
PANW
+$6.09M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$4.65M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$5.32M
2
AABA
Altaba Inc
AABA
+$4.73M
3
MGNX icon
MacroGenics
MGNX
+$3.45M
4
BAC icon
Bank of America
BAC
+$2.88M
5
RHT
Red Hat Inc
RHT
+$2.56M

Sector Composition

Rank Sector Weight
1 Technology 19.83%
2 Financials 18.55%
3 Consumer Discretionary 14.98%
4 Communication Services 14.5%
5 Healthcare 14.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NOW icon
251
ServiceNow
NOW
$132B
$505K 0.04%
21,500
– –
SBAC icon
252
SBA Communications
SBAC
$19.2B
$504K 0.04%
3,500
– –
OMC icon
253
Omnicom Group
OMC
$23.2B
$496K 0.04%
6,700
– –
KDP icon
254
Keurig Dr Pepper
KDP
$39.9B
$495K 0.04%
5,600
+300
+6% +$27.2K
APA icon
255
APA Corp
APA
$14.4B
$495K 0.04%
10,800
– –
DVN icon
256
Devon Energy
DVN
$49.9B
$492K 0.04%
13,400
– –
ALB icon
257
Albemarle
ALB
$15.5B
$491K 0.04%
3,600
+200
+6% +$23.8K
KLAC icon
258
KLA
KLAC
$252B
$488K 0.04%
46,000
– –
LHX icon
259
L3Harris
LHX
$54B
$487K 0.04%
3,700
– –
LH icon
260
Labcorp
LH
$26.1B
$483K 0.04%
3,725
+117
+3% +$15.6K
ESS icon
261
Essex Property Trust
ESS
$18.2B
$483K 0.04%
1,900
– –
KR icon
262
Kroger
KR
$34.6B
$481K 0.04%
24,000
+800
+3% +$18K
K
263
DELISTED
Kellanova
K
$480K 0.04%
8,201
+213
+3% +$13.5K
KEY icon
264
KeyCorp
KEY
$24.3B
$480K 0.04%
25,500
– –
AZO icon
265
AutoZone
AZO
$50.1B
$476K 0.04%
800
– –
CLX icon
266
Clorox
CLX
$13B
$475K 0.04%
3,600
+100
+3% +$13.4K
BMRN icon
267
BioMarin Pharmaceuticals
BMRN
$13.3B
$475K 0.04%
5,100
+100
+2% +$8.84K
AME icon
268
Ametek
AME
$58B
$472K 0.04%
7,150
+2,350
+49% +$149K
RF icon
269
Regions Financial
RF
$26.8B
$469K 0.04%
30,800
+2,200
+8% +$31.6K
NUE icon
270
Nucor
NUE
$62.5B
$465K 0.04%
8,300
– –
DTE icon
271
DTE Energy
DTE
$28.5B
$462K 0.04%
5,053
– –
MCHP icon
272
Microchip Technology
MCHP
$44.2B
$458K 0.04%
10,200
– –
PFG icon
273
Principal Financial Group
PFG
$24.4B
$457K 0.04%
7,100
– –
BXP icon
274
Boston Properties
BXP
$10.8B
$455K 0.04%
3,700
– –
LVLT
275
DELISTED
Level 3 Communications Inc
LVLT
$448K 0.04%
8,400
+500
+6% +$27.9K
9 10
11
12 13

Similar funds

IWM
IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return
CW
CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return
IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $4.31B AUM 21.13% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
NEI
Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return
CIC
Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return
SLI
Sumitomo Life Insurance Tokyo, Japan $4.25B AUM 23.69% 1-Year Est. Return

E. Ohman J:or Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, E. Ohman J:or Asset Management held 565 positions worth $1.13B, up 13% from $992M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

E. Ohman J:or Asset Management deployed $76.8M of net new capital in Q3 2017, opening 6 new positions and adding to 343 existing holdings. Its largest new stake was Teva Pharmaceuticals: 206,483 shares worth $3.63M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Hologic, an estimated $5.32M trimmed.

  • E. Ohman J:or Asset Management's largest Q3 2017 buy was Teva Pharmaceuticals: 206,483 shares worth $3.63M.
  • E. Ohman J:or Asset Management added most to Eli Lilly in Q3 2017, an estimated $11.6M increase.
  • E. Ohman J:or Asset Management's biggest Q3 2017 reduction was Hologic, cutting an estimated $5.32M.
  • E. Ohman J:or Asset Management fully exited MacroGenics in Q3 2017, selling an estimated $3.45M.
  • E. Ohman J:or Asset Management's ten largest holdings make up 30% of its $1.13B portfolio in Q3 2017.
  • E. Ohman J:or Asset Management opened 6 new positions and closed 6 in Q3 2017.
  • E. Ohman J:or Asset Management's portfolio value rose 13% quarter-over-quarter to $1.13B.

Based on E. Ohman J:or Asset Management's 13F filing for Q3 2017, filed 5 Apr 2024.